---
figid: PMC7569567__41573_2020_82_Fig2_HTML
figtitle: Kinase inhibition in autoimmunity and inflammation
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC7569567
filename: 41573_2020_82_Fig2_HTML.jpg
figlink: pmc/articles/PMC7569567/figure/Fig2/
number: F2
caption: The binding of extracellular ligands leads to pathway activation via changes
  to the receptors that permit trans-phosphorylation of associated Janus-associated
  kinases (JAKs). Activated JAKs then phosphorylate both the receptor and cognate
  signal transducer and activator of transcription (STAT) proteins. Activated and
  dimerized STATs then enter the nucleus to bind to transcriptional regulatory sites
  of target genes. Receptors that use JAK2 and JAK3, JAK3 alone, tyrosine kinase 2
  (TYK2) alone or JAK3 and TYK2 have not been described. EPO, erythropoietin; GH,
  growth hormone; GM-CSF, granulocyte–macrophage colony-stimulating factor; LIF, leukaemia
  inhibitory factor; OSM, oncostatin M; P, phosphorus; TPO, thrombopoietin; TSLP,
  thymic stromal lymphopoietin.
papertitle: Kinase inhibition in autoimmunity and inflammation.
reftext: Ali A. Zarrin, et al. Nat Rev Drug Discov. 2020 Oct 19 :1-25.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9219477
figid_alias: PMC7569567__F2
figtype: Figure
redirect_from: /figures/PMC7569567__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7569567__41573_2020_82_Fig2_HTML.html
  '@type': Dataset
  description: The binding of extracellular ligands leads to pathway activation via
    changes to the receptors that permit trans-phosphorylation of associated Janus-associated
    kinases (JAKs). Activated JAKs then phosphorylate both the receptor and cognate
    signal transducer and activator of transcription (STAT) proteins. Activated and
    dimerized STATs then enter the nucleus to bind to transcriptional regulatory sites
    of target genes. Receptors that use JAK2 and JAK3, JAK3 alone, tyrosine kinase
    2 (TYK2) alone or JAK3 and TYK2 have not been described. EPO, erythropoietin;
    GH, growth hormone; GM-CSF, granulocyte–macrophage colony-stimulating factor;
    LIF, leukaemia inhibitory factor; OSM, oncostatin M; P, phosphorus; TPO, thrombopoietin;
    TSLP, thymic stromal lymphopoietin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNG
  - IL26
  - IFNK
  - IFNW1
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNB1
  - IL22
  - IL24
  - APP
  - SUCLA2
  - IL17B
  - IL20
  - IL19
  - IL10
  - IL2
  - IL7
  - LINC02605
  - IL15
  - IL9
  - EPO
  - TIMP1
  - EPX
  - TPO
  - THPO
  - IL5
  - IL3
  - CSF2
  - LIF
  - TSLP
  - IL11
  - OSM
  - CCM2
  - IL4
  - IL13
  - IL6
  - IL37
  - IL23A
  - IL12A
  - IL12B
  - IFNL1
  - JAK3
  - TYK2
  - JAK2
  - STAT6
  - STAT3
  - STAT4
  - STAT1
  - STAT2
  - SOAT1
  - STAT5A
  - STAT5B
  - TRO
---
